Q3 2022 Holdings
Filed 2022-11-10 | 12 holdings | $34.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Invivyd Inc(IVVD) | COM | 00534A102 | $28.9M | 9,248,250 | 84.9% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $5.1M | 513,300 | 15.0% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $28.8K | 7,982,204 | 0.1% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $10.6K | 665,880 | 0.0% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $6.7K | 522,550 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $4.3K | 61,200 | 0.0% |
| Curis Inc(CRISEUR) | COM NEW | 231269200 | $3.1K | 4,482,142 | 0.0% |
| Verve Therapeutics Inc | COM | 92539P101 | $3.0K | 87,600 | 0.0% |
| Leap Therapeutics Inc | COM | 52187K101 | $2.3K | 2,664,400 | 0.0% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $2.0K | 338,800 | 0.0% |
| Proqr Thrapeutics N V | SHS EURO | N71542109 | $745 | 1,001,800 | 0.0% |
| Neximmune Inc | COM | 65344D109 | $74 | 133,442 | 0.0% |